Targeting DNA Repair Systems in Antitubercular Drug Development

Area of Science:

• Microbiology
• Molecular Biology
• Drug Discovery

Background:

• Tuberculosis (TB), caused by Mycobacterium tuberculosis, presents significant treatment challenges with existing drugs.
• There is an urgent clinical need for novel antitubercular compounds.
• DNA repair pathways are critical for M. tuberculosis survival and adaptation.

Purpose of the Study:

• To review the potential of DNA repair-associated proteins as targets for new anti-TB drug development.
• To highlight the essentiality and role of DNA repair genes in the TB pathogen's lifecycle and drug resistance.

Main Methods:

• Analysis of gene expression data to identify essential DNA repair genes.
• Review of protein crystal structures and known inhibitors of DNA repair proteins.
• Examination of mutant phenotypes in M. tuberculosis, Mycobacterium bovis, and Mycobacterium smegmatis.
• Summary of in vitro and in vivo studies on the role of DNA repair proteins in pathogenesis and virulence.

Main Results:

• DNA repair genes are essential during the pathogenic cycle and in response to antimicrobials.
• Structural information and inhibitors for several DNA repair proteins are available.
• DNA repair mechanisms contribute to mutation acquisition and the development of drug resistance in M. tuberculosis.

Conclusions:

• DNA repair-associated proteins represent promising targets for novel antitubercular drug discovery.
• Targeting these proteins could overcome existing drug resistance mechanisms and improve TB treatment efficacy.